Application 208862
- Type
- ANDA
- Sponsor
- ACTAVIS ELIZABETH
Related Records
Application Products
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RANOLAZINE | RANOLAZINE | TABLET, EXTENDED RELEASE;ORAL | 500MG | No | No |
| 002 | RANOLAZINE | RANOLAZINE | TABLET, EXTENDED RELEASE;ORAL | 1GM | No | No |
NDC Listings For This Application
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 45963-418 | Ranolazine | Ranolazine | Actavis Pharma, Inc. | ANDA | Current |
| 45963-418 | Ranolazine | Ranolazine | Actavis Pharma, Inc. | ANDA | Current |
| 45963-418 | Ranolazine | Ranolazine | Actavis Pharma, Inc. | ANDA | Current |
| 45963-418 | Ranolazine | Ranolazine | Actavis Pharma, Inc. | ANDA | Current |
| 45963-418 | Ranolazine | Ranolazine | Actavis Pharma, Inc. | ANDA | Current |
| 45963-419 | Ranolazine | Ranolazine | Actavis Pharma, Inc. | ANDA | Current |
| 45963-419 | Ranolazine | Ranolazine | Actavis Pharma, Inc. | ANDA | Current |
| 45963-419 | Ranolazine | Ranolazine | Actavis Pharma, Inc. | ANDA | Current |
| 45963-419 | Ranolazine | Ranolazine | Actavis Pharma, Inc. | ANDA | Current |
| 45963-419 | Ranolazine | Ranolazine | Actavis Pharma, Inc. | ANDA | Current |